Isoniazid preventive therapy in HIV infection

The Lancet

Volumn 377, Issue 9777, 2011, Pages 1548-1550

  Dodd, Lori Elizabeth ^a   Wilkinson, Robert John ^b,c,d  

^a NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

^b UNIVERSITY OF CAPE TOWN   (South Africa)

^c NATIONAL INSTITUTE FOR MEDICAL RESEARCH   (United Kingdom)

^d IMPERIAL COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT; ISONIAZID;

CD4 LYMPHOCYTE COUNT; DRUG EFFICACY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MIXED INFECTION; NOTE; PRIORITY JOURNAL; SHORT COURSE THERAPY; TREATMENT DURATION; TUBERCULIN TEST; TUBERCULOSIS;

EID: 79955699246     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(11)60434-0     Document Type: Note

References (12)

1. G Maartens, RJ Wilkinson Tuberculosis Lancet 370 2007 2030 2043 (Pubitemid 350236315)
2. MW Brinkhof, M Egger, A Boulle Tuberculosis after initiation of antiretroviral therapy in low-income and high-income countries Clin Infect Dis 45 2007 1518 1521 (Pubitemid 351411886)
3. GW Comstock, C Baum, DE Snider Jr. Isoniazid prophylaxis among Alaskan Eskimos: a final report of the Bethel isoniazid studies Am Rev Respir Dis 119 1979 827 830
4. C Akolo, I Adetifa, S Shepperd, J Volmink Treatment of latent tuberculosis infection in HIV infected persons Cochrane Database Syst Rev 1 2010 CD000171.
5. T Samandari, TB Agizew, S Nyirenda 6-month versus 36-month isoniazid preventive treatment for tuberculosis in adults with HIV infection in Botswana: a randomised, double-blind, placebo-controlled trial Lancet 2011 10.1016/S0140-6736(11)60204-3 published online April 13.
6. Stop TB Department Department of HIV/AIDS WHO Guidelines for intensified tuberculosis case-finding and isoniazid preventive therapy for people living with HIV in resource-constrained settings http://whqlibdoc.who.int/publications/ 2011/9789241500708-eng.pdf 2011 (accessed March 22, 2011).
7. JE Golub, V Saraceni, SC Cavalcante The impact of antiretroviral therapy and isoniazid preventive therapy on tuberculosis incidence in HIV-infected patients in Rio de Janeiro, Brazil AIDS 21 2007 1441 1448 (Pubitemid 46988004)
8. RB D'Agostino Jr. Propensity score methods for bias reduction in the comparison of a treatment to a non-randomized control group Stat Med 17 1998 2265 2281 (Pubitemid 28466823)
9. JM Robins, MA Hernan, B Brumback Marginal structural models and causal inference in epidemiology Epidemiology 11 2000 550 560 (Pubitemid 30660034)
10. M Pai, A Zwerling, D Menzies Systematic review: T-cell-based assays for the diagnosis of latent tuberculosis infection: an update Ann Intern Med 149 2008 177 184
11. KN Adams, K Takaki, LE Connolly Drug tolerance in replicating mycobacteria mediated by a macrophage-induced efflux mechanism Cell 145 2011 39 53
12. CE Barry 3rd, HI Boshoff, V Dartois The spectrum of latent tuberculosis: rethinking the biology and intervention strategies Nat Rev Microbiol 7 2009 845 855